Skip to main content

NuCana plc

NCNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001709626

No open-market purchases or sales by NuCana plc insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $167.9K in total; no superinvestor holds it.

Superinvestors holding NCNA, Q2 2026

See all superinvestors

No superinvestor reported holding NCNA in Q2 2026.